Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)’s share price rose 5.7% during trading on Friday after an insider bought additional shares in the company. The stock traded as high as $10.47 and last traded at $10.39. Approximately 4,335,410 shares changed hands during trading, an increase of 125% from the average daily volume of 1,924,612 shares. The stock had previously closed at $9.83.

Specifically, Director Yancey L. Spruill purchased 12,000 shares of the firm’s stock in a transaction on Wednesday, December 12th. The stock was purchased at an average cost of $10.07 per share, with a total value of $120,840.00. Following the purchase, the director now owns 59,843 shares in the company, valued at approximately $602,619.01. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Paul Black purchased 24,765 shares of the firm’s stock in a transaction on Wednesday, December 12th. The shares were purchased at an average cost of $10.10 per share, with a total value of $250,126.50. The disclosure for this purchase can be found here. 1.10% of the stock is owned by company insiders.

A number of brokerages have issued reports on MDRX. TheStreet raised Allscripts Healthcare Solutions from a “c+” rating to a “b-” rating in a research note on Thursday, September 6th. Zacks Investment Research lowered Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research note on Thursday, October 4th. Cantor Fitzgerald lowered Allscripts Healthcare Solutions from an “overweight” rating to a “neutral” rating and set a $12.00 price target for the company. in a research note on Thursday, November 1st. JPMorgan Chase & Co. lowered Allscripts Healthcare Solutions from an “overweight” rating to a “neutral” rating and decreased their price target for the company from $16.00 to $12.00 in a research note on Friday, November 2nd. Finally, SunTrust Banks lowered Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research note on Friday, November 2nd. Two analysts have rated the stock with a sell rating, five have issued a hold rating and eight have issued a buy rating to the stock. Allscripts Healthcare Solutions has a consensus rating of “Hold” and a consensus price target of $15.51.

The company has a market capitalization of $1.70 billion, a price-to-earnings ratio of 22.11, a price-to-earnings-growth ratio of 1.37 and a beta of 1.28. The company has a debt-to-equity ratio of 1.61, a current ratio of 0.94 and a quick ratio of 0.94.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings data on Thursday, November 1st. The software maker reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.14 by ($0.01). The company had revenue of $536.00 million for the quarter, compared to the consensus estimate of $546.09 million. Allscripts Healthcare Solutions had a positive return on equity of 8.25% and a negative net margin of 0.25%. The business’s revenue was up 18.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.15 earnings per share. Sell-side analysts anticipate that Allscripts Healthcare Solutions Inc will post 0.54 EPS for the current year.

Several institutional investors and hedge funds have recently added to or reduced their stakes in MDRX. Hennessy Advisors Inc. bought a new stake in shares of Allscripts Healthcare Solutions during the 3rd quarter worth $27,262,000. WINTON GROUP Ltd bought a new stake in shares of Allscripts Healthcare Solutions during the 3rd quarter worth $12,229,000. Rothschild & Co. Asset Management US Inc. bought a new stake in shares of Allscripts Healthcare Solutions during the 3rd quarter worth $12,218,000. Fuller & Thaler Asset Management Inc. boosted its stake in shares of Allscripts Healthcare Solutions by 10.7% during the 2nd quarter. Fuller & Thaler Asset Management Inc. now owns 6,836,652 shares of the software maker’s stock worth $82,040,000 after acquiring an additional 658,123 shares in the last quarter. Finally, Renaissance Technologies LLC bought a new stake in shares of Allscripts Healthcare Solutions during the 2nd quarter worth $7,352,000.

ILLEGAL ACTIVITY NOTICE: “Allscripts Healthcare Solutions (MDRX) Stock Price Up 5.7% Following Insider Buying Activity” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.thecerbatgem.com/2018/12/14/allscripts-healthcare-solutions-mdrx-stock-price-up-5-7-following-insider-buying-activity.html.

About Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Featured Story: Understanding Market Liquidity

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.